
Husband, Dad, Public Affairs @PhRMA | Fmr Cap Hill - E&C and Fred Upton | CMU & MSU alum
EL | DC
Joined March 2011
- Tweets5.2K
- Following517
- Followers1K
- Likes4.1K
New president and CEO, Eric Cantor, comes to PhRMA with a clear focus: finding common ground while ensuring new treatments and cures get to the patients who are counting on them.
In a new interview with @washingtonsun, he discusses how his experience in Congress and on Wall Street will shape his approach, why government price setting threatens future innovation and what’s at stake for patients if investment in U.S. research declines.
Read the full interview: washingtonsun.com/congress/e…
Tom Wilbur retweeted
“A lot of what we tried to do for the four years it took us to regain a majority was to present a value proposition for what an opposition party at that time was going to be,” Cantor said, suggesting that PhRMA needs to reshape its image in Washington as the industry that heals people.
“I mean, if you are sick or a member of your family is sick, what you want to hear is there’s a medicine for that, and these medicines that have come along now today are so miraculous.”
washingtonsun.com/congress/e…
State scrutiny of PBMs is far from over phrma.org/blog/state-scrutin…
1
80
NEW report: The biopharmaceutical industry in America directly employs more than 1 million people & drives $1.74 trillion in economic activity phrma.org/blog/the-1-74-tril…
43
Why 340B needs an itemized bill: phrma.org/blog/why-340b-need…
1
75
She’s a Republican. He’s a Democrat. Married 35 years.
One thing Amye and Charlie Joseph agree on? Frustration with PBMs controlling where they fill prescriptions and what they pay.
Taking on the powerful middlemen standing between patients and their medicines has become a bipartisan cause. Read more here: ow.ly/3AUT50ZVtNH
PhRMA Foundation makes unprecedented investment in America’s future scientific workforce
Learn more: phrma.org/blog/-phrma-founda…
57
As candidates make their case ahead of the midterms, the first-ever Voters for Cures/Morning Consult poll sends a clear message: voters are most concerned about rising health insurance costs.
votersforcures.org/resources…
1
79
Tom Wilbur retweeted
A new report finds hospitals, clinics and their for-profit partners generated $142B in profits from 340B medicine markups in 2025 alone. The evidence is clear: The debate is no longer whether the federal 340B program needs reform, but how to reform it to ensure the program serves the patients it was created to help. Learn more: ow.ly/o8wQ50ZTs4p
New poll shows voters want policymakers to tackle health insurance costs votersforcures.org/resources…
We are excited to announce Eric Cantor as our next president and CEO.
Eric is well respected among policy leaders in Washington and around the world, with a long track record of working effectively across the political spectrum in support of biomedical research and patients’ access to medicines. He joins PhRMA at a pivotal moment for America’s biopharmaceutical industry.
Read more: phrma.org/resources/phrma-se…
Vaccines Remain Our Most Important Public Health Tool votersforcures.org/advocate-…
2
57
ICYMI: Biopharmaceutical companies in America hit new investment milestone phrma.org/blog/icymi-biophar…
62
Nearly 1 in 4 patients initially denied access to IRA medicines phrma.org/blog/nearly-1-in-4…
1
64
Tom Wilbur retweeted
Why is there a whole lot more talk about drug prices than hospital prices?
Paraphrasing bank robber Willie Sutton: If we want to restrain health spending, we have to go where the money is -- hospitals.
@JAMA_current @JAMAHealthForum
jamanetwork.com/journals/jam…
Guest Blog: Price controls won’t lower costs when insurers control access phrma.org/blog/guest-blog-pr…
2
68
. @robzirk in @thehill: Cheaper medicines exist — middlemen are keeping them out of reach thehill.com/opinion/healthca…
1
83
Tom Wilbur retweeted
. @SteveUbl runs @PhRMA, one of the most powerful lobbies in Washington. He joined @BrodyMullinsDC and @camoosomiller on The Deciders to talk gene therapy, pharmacy middlemen, AI, and the innovation race with China. New episode. youtu.be/-ap2B0pBxSg
Staffing up: Building the future biopharma workforce to keep America in the lead phrma.org/blog/staffing-up-b…
1
53
State price-setting boards create more questions than answers phrma.org/blog/state-price-s…
60






